ER-mediated anti-tumor effects of shikonin on breast cancer.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2019.172667
Abstract: Estrogen receptor (ER) is expressed in most Breast cancer (BC) patients. G protein-coupled estrogen receptor (GPER), which is a membrane-bound estrogen receptor, is associated with the tumor development and progression in BC. Shikonin (SK) is… read more here.
Keywords: estrogen; breast cancer; tumor effects; anti tumor ... See more keywords